BACKGROUND: This study aimed to evaluate the long-term risk of local and distant recurrence as well as the survival of patients with early rectal cancer treated using transanal endoscopic microsurgery (TEM). METHODS: The study reviewed 69 patients with Tis/T1/T2 rectal cancer treated using full-thickness excision between 1991 and 1999. The pathology T-stages included 25 Tis, 23 T1, and 21 T2. The median follow-up period was 6.5 years (range 5-10.2 years). RESULTS: The overall local recurrence rate was 8.7%. The 5-year local recurrence rate was 8% for Tis, 8.6% for T1, and 9.5% for T2. All six patients with recurrence were managed surgically. The 5-year disease-specific survival rate was 100% for Tis, 100% for T1, and 70% for T2. The overall cancer-related mortality rate was 7.2%. CONCLUSIONS: After local excision of early rectal cancer, a substantial local recurrence rate is observed. Patients with recurrent Tis/T1 cancers who undergo a salvage operation may achieve good long-term outcome. Local treatment without adjuvant therapy for T2 rectal cancers appears inadequate.
BACKGROUND: This study aimed to evaluate the long-term risk of local and distant recurrence as well as the survival of patients with early rectal cancer treated using transanal endoscopic microsurgery (TEM). METHODS: The study reviewed 69 patients with Tis/T1/T2 rectal cancer treated using full-thickness excision between 1991 and 1999. The pathology T-stages included 25 Tis, 23 T1, and 21 T2. The median follow-up period was 6.5 years (range 5-10.2 years). RESULTS: The overall local recurrence rate was 8.7%. The 5-year local recurrence rate was 8% for Tis, 8.6% for T1, and 9.5% for T2. All six patients with recurrence were managed surgically. The 5-year disease-specific survival rate was 100% for Tis, 100% for T1, and 70% for T2. The overall cancer-related mortality rate was 7.2%. CONCLUSIONS: After local excision of early rectal cancer, a substantial local recurrence rate is observed. Patients with recurrent Tis/T1 cancers who undergo a salvage operation may achieve good long-term outcome. Local treatment without adjuvant therapy for T2 rectal cancers appears inadequate.
Authors: C Langer; T Liersch; M Süss; A Siemer; P Markus; B M Ghadimi; L Füzesi; H Becker Journal: Int J Colorectal Dis Date: 2002-12-14 Impact factor: 2.571
Authors: J F Bosset; V Magnin; P Maingon; G Mantion; E P Pelissier; M Mercier; G Chaillard; J C Horiot Journal: Int J Radiat Oncol Biol Phys Date: 2000-01-15 Impact factor: 7.038
Authors: Charles M Friel; John W Cromwell; Claudio Marra; Robert D Madoff; David A Rothenberger; Julio Garcia-Aguílar Journal: Dis Colon Rectum Date: 2002-07 Impact factor: 4.585
Authors: Angelo Restivo; Luigi Zorcolo; Giuseppe D'Alia; Francesca Cocco; Andrea Cossu; Francesco Scintu; Giuseppe Casula Journal: Int J Colorectal Dis Date: 2015-08-23 Impact factor: 2.571
Authors: Antonio Maya; Andrew Vorenberg; Myrian Oviedo; Giovanna da Silva; Steven D Wexner; Dana Sands Journal: Surg Endosc Date: 2013-12-24 Impact factor: 4.584
Authors: Franz Georg Bader; Uwe Johannes Roblick; Elisabeth Oevermann; Hans-Peter Bruch; Oliver Schwandner Journal: Int J Colorectal Dis Date: 2008-04 Impact factor: 2.571